Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Corné J[au]:

Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease. Daffa NI et al. Clin Exp Immunol. (2015)

Standards of care for occupational asthma. Fishwick D et al. Thorax. (2008)

Mechanisms of virus induced exacerbations of asthma. Corne JM et al. Thorax. (1997)

Search results

Items: 31

1.

Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer.

De La Motte Rouge T, Corné J, Cauchois A, Le Boulch M, Poupon C, Henno S, Rioux-Leclercq N, Le Pabic E, Laviolle B, Catros V, Levêque J, Fautrel A, Le Gallo M, Legembre P, Lavoué V.

Mol Cancer Res. 2019 Dec;17(12):2537-2548. doi: 10.1158/1541-7786.MCR-19-0449. Epub 2019 Sep 19.

PMID:
31537619
2.

Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease.

Daffa NI, Tighe PJ, Corne JM, Fairclough LC, Todd I.

Clin Exp Immunol. 2015 Apr;180(1):155-63. doi: 10.1111/cei.12565.

3.

Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Wang J, Urbanowicz RA, Tighe PJ, Todd I, Corne JM, Fairclough LC.

PLoS One. 2013;8(3):e58556. doi: 10.1371/journal.pone.0058556. Epub 2013 Mar 11.

4.

Standards of care for occupational asthma: an update.

Fishwick D, Barber CM, Bradshaw LM, Ayres JG, Barraclough R, Burge S, Corne JM, Cullinan P, Frank TL, Hendrick D, Hoyle J, Curran AD, Niven R, Pickering T, Reid P, Robertson A, Stenton C, Warburton CJ, Nicholson PJ.

Thorax. 2012 Mar;67(3):278-80. doi: 10.1136/thoraxjnl-2011-200755. Epub 2011 Dec 9.

PMID:
22156958
5.

Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership.

Eleftheriadou V, Whitton ME, Gawkrodger DJ, Batchelor J, Corne J, Lamb B, Ersser S, Ravenscroft J, Thomas KS; vitiligo priority setting partnership.

Br J Dermatol. 2011 Mar;164(3):530-6. doi: 10.1111/j.1365-2133.2010.10160.x. Epub 2011 Jan 28.

6.

Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.

Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC.

Respir Res. 2010 Jun 11;11:76. doi: 10.1186/1465-9921-11-76.

7.

The trainee-led clinicopathological conference: an innovative method for educating medical trainees.

Potton E, Little J, Campbell J, Hind J, Corne J.

Clin Med (Lond). 2010 Feb;10(1):34-6.

8.

Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells.

Lane N, Robins RA, Corne J, Fairclough L.

Clin Sci (Lond). 2010 Apr 20;119(2):75-86. doi: 10.1042/CS20100033. Review.

PMID:
20402669
9.

Quantitative validation and comparison of multiplex cytokine kits.

Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P, Fairclough L.

J Biomol Screen. 2010 Jun;15(5):562-8. doi: 10.1177/1087057110362099. Epub 2010 Feb 22.

PMID:
20176857
10.

Altered effector function of peripheral cytotoxic cells in COPD.

Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC.

Respir Res. 2009 Jun 22;10:53. doi: 10.1186/1465-9921-10-53.

11.

Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Richens JL, Urbanowicz RA, Lunt EA, Metcalf R, Corne J, Fairclough L, O'Shea P.

Respir Res. 2009 Apr 22;10:29. doi: 10.1186/1465-9921-10-29. Review.

12.

Killer cells in chronic obstructive pulmonary disease.

Fairclough L, Urbanowicz RA, Corne J, Lamb JR.

Clin Sci (Lond). 2008 Apr;114(8):533-41. doi: 10.1042/CS20070356. Review.

PMID:
18336369
13.

MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.

Lowrey GE, Henderson N, Blakey JD, Corne JM, Johnson SR.

Respir Med. 2008 Jun;102(6):845-51. doi: 10.1016/j.rmed.2008.01.006. Epub 2008 Mar 6.

14.

Standards of care for occupational asthma.

Fishwick D, Barber CM, Bradshaw LM, Harris-Roberts J, Francis M, Naylor S, Ayres J, Burge PS, Corne JM, Cullinan P, Frank TL, Hendrick D, Hoyle J, Jaakkola M, Newman-Taylor A, Nicholson P, Niven R, Pickering A, Rawbone R, Stenton C, Warburton CJ, Curran AD; British Thoracic Society Standards of Care Subcommittee Guidelines on Occupational Asthma.

Thorax. 2008 Mar;63(3):240-50. Epub 2007 Sep 28. Review. No abstract available.

15.

Increased frequency of detection of Chlamydophila pneumoniae in asthma.

Biscione GL, Corne J, Chauhan AJ, Johnston SL.

Eur Respir J. 2004 Nov;24(5):745-9.

16.

Pulmonary expression of leukemia inhibitory factor induces B cell hyperplasia and confers protection in hyperoxia.

Wang J, Chen Q, Corne J, Zhu Z, Lee CG, Bhandari V, Homer RJ, Elias JA.

J Biol Chem. 2003 Aug 15;278(33):31226-32. Epub 2003 Jun 2.

17.

Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.

Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, Johnston SL.

Lancet. 2002 Mar 9;359(9309):831-4.

PMID:
11897281
18.

The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection.

Corne JM, Lau L, Scott SJ, Davies R, Johnston SL, Howarth PH.

Am J Respir Crit Care Med. 2001 Apr;163(5):1101-7.

PMID:
11316643
19.

IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.

Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, Waxman AB, Elias JA.

J Clin Invest. 2000 Sep;106(6):783-91.

20.

A multiplex RT-PCR for the detection of parainfluenza viruses 1-3 in clinical samples.

Corne JM, Green S, Sanderson G, Caul EO, Johnston SL.

J Virol Methods. 1999 Sep;82(1):9-18.

PMID:
10507408
21.

Do inhaled corticosteroids reduce serum IgE levels? The answer is maybe but how relevant is the question?

Corne J.

Clin Exp Allergy. 1999 Mar;29(3):294-7. No abstract available.

PMID:
10202334
22.

Effect of systemic beta-agonist therapy on IgE production in allergic subjects in vivo.

Corne JM, Linaker CH, Howarth PH, Lau LC, Merrett T, Beasely R, Church M.

J Allergy Clin Immunol. 1998 Nov;102(5):727-31.

PMID:
9819288
23.

Treatment of allergic airways disease with anti-IgE.

Holgate ST, Corne J, Jardieu P, Fick RB, Heusser CH.

Allergy. 1998;53(45 Suppl):83-8. Review. No abstract available.

PMID:
9788714
24.

Mechanisms of virus induced exacerbations of asthma.

Corne JM, Holgate ST.

Thorax. 1997 Apr;52(4):380-9. Review. No abstract available.

25.

[Not Available].

Sampson AP, Corne JM, Holgate ST.

BioDrugs. 1997 Mar;7(3):167-74.

PMID:
18031091
26.

The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.

Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilchherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S.

J Clin Invest. 1997 Mar 1;99(5):879-87.

27.

Diffuse panbronchiolitis--a new Japanese export?

Corne J.

Lancet. 1996 Nov 30;348(9040):1465-6. No abstract available.

PMID:
8942772
28.

Asthma: basis and management at different ages.

Chanarin N, Corne J, Holgate ST.

Respir Med. 1995 Jul;89(6):409-13. No abstract available.

29.

Prevalence of atopy in asthma.

Corne J, Smith S, Schreiber J, Holgate ST.

Lancet. 1994 Jul 30;344(8918):344-5. No abstract available.

PMID:
7914295
30.

Respiratory viruses and asthma. Importance of infection underestimated.

Corne J, Chanarin N.

BMJ. 1994 Jan 1;308(6920):57. No abstract available.

31.

A critical appraisal of coagulation studies prior to transfemoral angiography.

Wilson NV, Corne JM, Given-Wilson RM.

Br J Radiol. 1990 Feb;63(746):147-8. No abstract available.

PMID:
2310911

Supplemental Content

Support Center